{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:51:48Z","timestamp":1779223908752,"version":"3.51.4"},"reference-count":47,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2018.1645","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T09:39:02Z","timestamp":1528191542000},"source":"Crossref","is-referenced-by-count":6,"title":["Induction chemotherapy in patients with resectable laryngeal cancer: A meta-analysis"],"prefix":"10.3892","author":[{"given":"Pei","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"Suppl 8","key":"key20200713201937_b1-mco-0-0-1645","first-page":"1","article-title":"Head and neck cancer: Overview of recent developments and future directions","volume":"27","author":"Forastiere","year":"2000","journal-title":"Semin Oncol"},{"key":"key20200713201937_b2-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"TAX 324 Study Group: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"key20200713201937_b3-mco-0-0-1645","first-page":"61","article-title":"Induction chemotherapy inpatients with resectable head and neck squamous cell carcinoma: A Meta-analysis","volume":"11","author":"Jie","year":"2013","journal-title":"World J Surg Oncol"},{"key":"key20200713201937_b4-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"key20200713201937_b5-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/annonc\/mdf172","article-title":"End points for new agents in induction chemotherapy for locally advanced head and neck cancers","volume":"13","author":"Monnerat","year":"2002","journal-title":"Ann Oncol"},{"key":"key20200713201937_b6-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"key20200713201937_b7-mco-0-0-1645","first-page":"CD006387","article-title":"Interventions for the treatment of oral cavity and oropharyngeal cancer: Radiotherapy","volume":"4","author":"Glenny","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713201937_b8-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"key20200713201937_b9-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key20200713201937_b10-mco-0-0-1645","first-page":"4055","article-title":"Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis","volume":"6","author":"Mitsudomi","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20200713201937_b11-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key20200713201937_b12-mco-0-0-1645","first-page":"83","article-title":"Analysing means and proportions","volume-title":"Statistical Methods in Medical Research","author":"Armitage","year":"2008","edition":"4th edition"},{"key":"key20200713201937_b13-mco-0-0-1645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.21294","article-title":"Reexamining the treatment of advanced laryngeal cancer","volume":"32","author":"Olsen","year":"2010","journal-title":"Head Neck"},{"key":"key20200713201937_b14-mco-0-0-1645","first-page":"6473","article-title":"Osthole induces apoptosis, suppresses cell-cycle progression and proliferation of cancer cells","volume":"34","author":"Jarz\u0105b","year":"2014","journal-title":"Anticancer Res"},{"key":"key20200713201937_b15-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/hed.23263","article-title":"Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer","volume":"36","author":"Dewyer","year":"2014","journal-title":"Head Neck"},{"key":"key20200713201937_b16-mco-0-0-1645","first-page":"S24","article-title":"Laryngeal preservation: nonsurgical approaches","volume":"8","author":"Bourhis","year":"2004","journal-title":"Cancer Radiother"},{"key":"key20200713201937_b17-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.canrad.2016.07.018","article-title":"Radiotherapy of larynx cancers","volume":"20","author":"Pointreau","year":"2016","journal-title":"Cancer Radiother"},{"key":"key20200713201937_b18-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.canrad.2013.06.038","article-title":"Induction chemotherapy for locally advanced head and neck cancer","volume":"17","author":"Calais","year":"2013","journal-title":"Cancer Radiother"},{"key":"key20200713201937_b19-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canrad.2013.06.047","article-title":"Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension","volume":"18","author":"L\u00e9vy","year":"2014","journal-title":"Cancer Radiother"},{"key":"key20200713201937_b20-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1200\/JCO.2015.61.2978","article-title":"Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes","volume":"33","author":"Forastiere","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20200713201937_b21-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1288\/00005537-198704000-00002","article-title":"The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies","volume":"97","author":"Toohill","year":"1987","journal-title":"Laryngoscope"},{"key":"key20200713201937_b22-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3322\/canjclin.48.4.211","article-title":"Advances in multimodality therapy for laryngeal cancer","volume":"48","author":"Carew","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"key20200713201937_b23-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0030-6665(02)00035-X","article-title":"Organ preservation trials for laryngeal cancer","volume":"35","author":"Gilbert","year":"2002","journal-title":"Otolaryng Clin N Am"},{"key":"key20200713201937_b24-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.21873\/anticanres.11269","article-title":"Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma","volume":"36","author":"Gorphe","year":"2016","journal-title":"Anticancer Res"},{"key":"key20200713201937_b25-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"Wolf","year":"1991","journal-title":"N Engl J Med"},{"key":"key20200713201937_b26-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/(SICI)1097-0347(199609\/10)18:5<405::AID-HED3>3.0.CO;2-9","article-title":"Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer","volume":"18","author":"Zelefsky","year":"1996","journal-title":"Head Neck"},{"key":"key20200713201937_b27-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S1368-8375(97)00090-0","article-title":"Randomized trial of induction chemotherapy in larynx carcinoma","volume":"34","author":"Richard","year":"1998","journal-title":"Oral Oncol"},{"key":"key20200713201937_b28-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"key20200713201937_b29-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/00016480902914080","article-title":"Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma","volume":"130","author":"Prades","year":"2010","journal-title":"Acta Otolaryngol"},{"key":"key20200713201937_b30-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1093\/annonc\/mds065","article-title":"Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891","volume":"23","author":"Lefebvre","year":"2012","journal-title":"Ann Oncol"},{"key":"key20200713201937_b31-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91\u201311: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20200713201937_b32-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s00066-014-0647-8","article-title":"Squamous cell carcinoma of the larynx with subglottic extension: Is larynx preservation possible?","volume":"190","author":"Levy","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"key20200713201937_b33-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/00016489.2014.968673","article-title":"Contemporary therapeutic management of locally advanced hypopharyngeal cancer: Oncologic and functional outcomes - a report on 100 cases","volume":"135","author":"Vandersteen","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"key20200713201937_b34-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1470-2045(10)70279-5","article-title":"Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: Long-term results of the TAX 324 randomised phase 3 trial","volume":"12","author":"Lorch","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20200713201937_b35-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"8","author":"Lefebvre","year":"1996","journal-title":"Journal of the National Cancer Institute"},{"key":"key20200713201937_b36-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jnci\/djn460","article-title":"EORTC Head and Neck Cancer Cooperative Group; EORTC Radiation Oncology Group: Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy","volume":"101","author":"Lefebvre","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key20200713201937_b37-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20200713201937_b38-mco-0-0-1645","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00029330-200810010-00016","article-title":"Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: A meta-analysis","volume":"121","author":"Su","year":"2008","journal-title":"Chin Med J (Engl)"},{"issue":"Suppl 1","key":"key20200713201937_b39-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2007.05.072","article-title":"Response to Therapy and Outcome in Oropharyngeal Cancer are Associated with Biomarkers Including HPV, EGFR, Gender and Smoking","volume":"69","author":"Kumar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15 Suppl 3","key":"key20200713201937_b40-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1634\/theoncologist.2010-S3-19","article-title":"TPF: a rational choice for larynx preservation?","author":"Calais","year":"2010","journal-title":"Oncologist"},{"key":"key20200713201937_b41-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-4598-10-12","article-title":"Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma","volume":"10","author":"Wilken","year":"2011","journal-title":"Mol Cancer"},{"issue":"902716","key":"key20200713201937_b42-mco-0-0-1645","article-title":"Curcumin and Other Polyphenolic Compounds in Head and Neck Cancer Chemoprevention","volume":"2012","author":"Baumeister","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"key20200713201937_b43-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3892\/etm.2017.4420","article-title":"Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK\/TGF-\u03b21 pathway","volume":"13","author":"Qiao","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20200713201937_b44-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"394264","DOI":"10.1155\/2014\/394264","article-title":"Nanotechnology-applied curcumin for different diseases therapy","volume":"2014","author":"Ghalandarlaki","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20200713201937_b45-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/ol.2014.2834","article-title":"Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression","volume":"9","author":"Li","year":"2015","journal-title":"Oncol Lett"},{"key":"key20200713201937_b46-mco-0-0-1645","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ng.3090","article-title":"Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population","volume":"46","author":"Wei","year":"2014","journal-title":"Nat Genet"},{"key":"key20200713201937_b47-mco-0-0-1645","first-page":"1357","article-title":"In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells","volume":"124","author":"Liang","year":"2011","journal-title":"Chin Med J (Engl)"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T08:27:49Z","timestamp":1720340869000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2018.1645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3892\/mco.2018.1645","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]}}}